MedTrace Logo

A Clinical Study to Evaluate the Absorption, Metabolism, and Excretion of Oral [14C]GS1-144 in Healthy Postmenopausal Female Participants

NCT07537231 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2026-05-07

No results posted yet for this study

Summary

This is a single-center, non-randomized, open-label, single-dose clinical PK study in healthy postmenopausal female participants.

Conditions

  • Metabolism
  • Excretion
  • Healthy Postmenopausal Women
  • Absorption

Interventions

DRUG

[14C]GS1-144

30 mg/100 µCi \[14C\]GS1-144, taken orally once

Sponsors & Collaborators

  • Changchun GeneScience Pharmaceutical Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-09
Primary Completion
2026-04-18
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07537231 on ClinicalTrials.gov